Patents Represented by Attorney, Agent or Law Firm Medlen & Carroll, LLP
  • Patent number: 7811996
    Abstract: The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: October 12, 2010
    Assignee: The Regents of the University of California
    Inventor: Michael David
  • Patent number: 7810501
    Abstract: The present invention is a simple, adaptable orthotic device that can correct and/or prevent deformational posterior plagiocephaly, especially if used before the infant is 4 months of age. The manufactured article provides an anatomically correcting, adjustable, concave-shaped resting surface for an infant's head in a manner that effectively eliminates uneven pressure on the infant's occiput. The orthotic device has a module design which permits easy adjustments of the devices' head cavity to accommodate differences in individual infant head size and shape, thereby providing the infant's head with a custom fit. Also, as the infant continues to grow in size, the adjustable head cavity and torso recess features of the orthotic device allow the contoured spatial volume and dimensions of the molded supporting surfaces to expand as the infant's calvaria grow; and thereby facilitate a progressive, normalization and rounding of the infant's occiput.
    Type: Grant
    Filed: September 24, 2007
    Date of Patent: October 12, 2010
    Assignees: Boston Brace, Children's Hospital Boston
    Inventors: Gary F Rogers, James R Miller
  • Patent number: 7807407
    Abstract: This invention relates to the detection and analysis by mass spec of nascent proteins, and in particular truncated proteins, translated within cellular or cell-free translation systems. N-terminal and C-terminal epitopes introduced into these nascent proteins permit rapid and efficient isolation, as well as a mass difference.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: October 5, 2010
    Assignee: AmberGen, Inc.
    Inventors: Alex M. Garvin, Sadanand Gite, Vladislav B. Bergo, Kenneth J. Rothschild
  • Patent number: 7803594
    Abstract: The invention relates to enzymes in Trypanosoma brucei, and in particular, protein arginine methyltransferases. A unique, highly active recombinant arginine methyltransferase capable of monomethylation of peptides and proteins is described.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: September 28, 2010
    Assignee: University of Buffalo, Office of Science & Tech Transfer
    Inventors: Laurie K. Read, John Fisk
  • Patent number: 7794951
    Abstract: The present invention relates to methods and compositions for modulating fertility. In particular the present invention provides cell lines and transgenic animals for use in identifying modulators of SREBP2gc transcription factors. The present invention further provides therapeutic agents that modulate SREBP2gc signaling for use as fertility modulators.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: September 14, 2010
    Assignee: University of Massachusetts Medical School
    Inventors: Daniel Kilpatrick, Hang Wang
  • Patent number: 7781648
    Abstract: The present invention relates to compositions and methods for providing aphid resistance in plants. More particularly, the invention relates to compositions and methods for using aphid resistant germplasm for breeding soybean aphid resistant soybean plants, including but not limited to cultivars, varieties, lines and methods of breeding the same for commercial use, the breeding methods further involving identifying and using genetic markers for aphid resistant traits.
    Type: Grant
    Filed: May 18, 2006
    Date of Patent: August 24, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Dechun Wang, Clarice Mensah, Christina D. DiFonzo
  • Patent number: 7776527
    Abstract: The present invention relates to microbial infection, and in particular, the reduction of apoptosis associated with microbial infection, the screening of agents that reduce apoptosis, and the treatment and analysis of microbial infection in vivo. In one embodiment, the present invention relates to agents including but not limited to reducing the activity of Protein Kinase R.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: August 17, 2010
    Assignee: The Regents of the University of California
    Inventors: Li-Chung Hsu, Michael Karin
  • Patent number: 7772459
    Abstract: The invention relates to the production of proteins and other substances of interest in saliva of transgenic animals, particularly in mammals that produce large quantities of saliva, particularly monogastric ruminants, and ovine, caprine and bovine mammals. Preferred embodiments of the invention relate in particular to the production of foreign and modified proteins in the transgenic saliva of these animals, including particularly human fibrinogen, human prothrombin and human thrombin, among others. The invention relates as well to methods, devices, genetic constructs and to transgenic constructs for making the proteins and other substances of interest, to novel saliva and saliva-derived compositions, novel products from the saliva, and to uses of the saliva, saliva-derived compositions and novel products.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: August 10, 2010
    Assignee: Bellweather Farms
    Inventor: Jeffrey P. Erickson
  • Patent number: 7767789
    Abstract: Methods/reagents for detecting and/or treating cancers or potential cancers are disclosed. In one embodiment, methods and reagents for detecting truncated forms of P2X7 protein in cells are described. In one embodiment, methods and reagents for increasing the amount and/or activity of full-length P2X7 in cells are described. In one embodiment, methods and reagents for decreasing the amount and/or activity of truncated P2X7 in cells are described.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: August 3, 2010
    Assignees: University Hopitals of Cleveland, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: George Gorodeski, Ying-Hong Feng, Xin Li
  • Patent number: 7754190
    Abstract: Neurophysiologic information such as quantitative electroencephalography (QEEG) is used in a method for classifying, diagnosing, and treating physiologic brain imbalances. Neurophysiologic information is also used to guide sample selection in clinical tests for psychopharmacologic drug candidates. Finally, neurophysiologic information is used for remotely assessing and treating patients with physiologic brain imbalances.
    Type: Grant
    Filed: June 23, 2003
    Date of Patent: July 13, 2010
    Assignee: CNS Response, Inc.
    Inventor: Stephen Suffin
  • Patent number: 7750135
    Abstract: The present invention relates to compositions and methods utilizing thermostable and novel alcohol dehydrogenase enzymes for biosynthesizing chiral specific molecules for use as precursor molecules in synthesizing pharmaceutical compounds. Particularly, in preferred embodiments, the invention relates to directed engineering of an enzymatic catalytic site of an alcohol dehydrogenase enzyme gene for enhancing enantioselectivity for (S)-enantiomer substrate catalytic activity for providing aryl (S)-enantiomer products in stereomeric excess.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: July 6, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: J. Gregory Zeikus, Karla I. Ziegelmann-Fjeld, Claire Vieille
  • Patent number: 7745570
    Abstract: A novel peptide adhesive motif is described that requires no receptor or cross-links to achieve maximal adhesive strength. Several peptides with different degrees of adhesive strength have been designed and synthesized using solid phase chemistries. All peptides contain a common hydrophobic core sequence flanked by positively or negatively charged amino acids sequences.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: June 29, 2010
    Assignee: Kansas State University Research Foundation
    Inventors: John Tomich, Takeo Iwamoto, Xinchun Shen, Xiuzhi Susan Sun
  • Patent number: 7745602
    Abstract: The present inventions relate to compositions and methods for providing drought resistant grass plants comprising Festuca mairei plant germplasm. Specifically, the inventions relate to providing compositions and methods for introgressing Festuca mairei germplasm and/or specific Festuca mairei genes into grass plants, such as Lolium perenne plants. Further, the invention relates to methods of grass plant breeding comprising genetic markers for identifying the preferred Festuca mairei germplasm introgressed into grass plants, and providing commercially desirable drought resistant cultivars of grass plants.
    Type: Grant
    Filed: February 7, 2008
    Date of Patent: June 29, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventor: Suleiman Bughrara
  • Patent number: 7732436
    Abstract: The synthesis and biological activity of indoloazepines and acid amine salts thereof which are structurally related to naturally-occurring hymenialdisine is disclosed. Naturally-occurring hymenialdisine obtained from the sponge is a potent inhibitor of production of cytokines interleukin-2 (IL-2) and tumor necrosis factor-? (TNF-?). The chemically-synthesized indoloazepines of the invention also inhibit production of IL-2 and TNF-?. The indoloazepines are useful for treating inflammatory diseases, particularly diseases associated with kinases NF-?B or GSK-3? activation or NF-?B activated gene expression products. The indoloazepines are useful for the treatment of cancer by the inhibition of kinases CHK1 and CHK2.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: June 8, 2010
    Assignee: Board Of Trustees Of Michigan State University
    Inventor: Jetze J. Tepe
  • Patent number: 7695921
    Abstract: The present invention relates to compositions and methods for cancer diagnosis, treatment and drug screening. In particular, the present invention provides compositions and methods for targeting the nuclear translocation of IkB kinase-? (IKK?) and the IKK?-mediated suppression of Maspin expression observed in metastatic prostate cancer cells.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: April 13, 2010
    Assignee: The Regents of the University of California
    Inventors: Michael Karin, Jun-Li Luo, Wei Tan
  • Patent number: 7696148
    Abstract: The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: April 13, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Marc Peters-Golden, Theodore Standiford
  • Patent number: 7682794
    Abstract: The present application is in the field of sialic acid chemistry, metabolism and antigenicity. More particularly, the present invention relates to the detection and analysis of the non-human sialic acid, N-glycolylneuraminic acid (Neu5Gc) in bio-logical materials, such as food and clinical specimens. Such detection and analysis is facilitated by the use of Neu5Gc specific antibodies. The present invention also relates to the detection of anti Neu5Gc antibodies in clinical samples, as well as the production of anti-Neu5Gc specific antibodies.
    Type: Grant
    Filed: July 14, 2004
    Date of Patent: March 23, 2010
    Assignee: The Regents of the University of California
    Inventors: Ajit Varki, Pam Tangvoranuntakul, Nissi Varki, Elaine Muchmore, Pascal Gagneux, Sandra Diaz
  • Patent number: 7674214
    Abstract: The invention relates to methods and an apparatus used to lift a barbell. In some embodiments, the invention relates to an apparatus having a centralized handle and opposing hooks extending away from and attached to opposing ends of said handle. In other embodiments, the invention relates to methods for attaching said hooks to a barbell to assist in the performance of weight-bearing exercise and lifting.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: March 9, 2010
    Inventors: David Marethouse, Johnny Kloesel
  • Patent number: 7667099
    Abstract: The present invention relates to genes encoding proteins involved in prokaryotic type or plastid division and/or morphology and the encoded proteins, and in particular to isolated Ftn2 (ARC6), ARC5, and Fzo-like genes and polypeptides. The present invention also provides methods for using Ftn2 (ARC6), ARC5, and Fzo-like genes, and polypeptides.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: February 23, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Katherine W. Osteryoung, Stanislav Vitha, Olga A. Koksharova, Hongbo Gao
  • Patent number: PP20841
    Abstract: A new Raspberry plant particularly distinguished by being a primocane raspberry plant having favourable fruit color and flavour, large and firm berry, and good tolerance to raspberry pests and diseases, is disclosed.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: March 16, 2010
    Assignee: Centro Di Ricerca per La Frutticoltura
    Inventors: Antonio Pititto, Luigi Gadler, Flavio Roberto De Salvador